Edition:
United States

CVS Health Corp (CVS)

CVS on New York Consolidated

78.49USD
24 Mar 2017
Change (% chg)

$0.19 (+0.24%)
Prev Close
$78.30
Open
$78.25
Day's High
$78.66
Day's Low
$78.01
Volume
3,878,592
Avg. Vol
7,445,434
52-wk High
$106.67
52-wk Low
$69.30

CVS

Chart for CVS

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.84
Market Cap(Mil.): $80,507.16
Shares Outstanding(Mil.): 1,025.70
Dividend: 0.50
Yield (%): 2.55

Financials

  CVS Industry Sector
P/E (TTM): 15.93 19.45 39.76
EPS (TTM): 4.93 -- --
ROI: 7.74 11.43 61.97
ROE: 14.30 13.03 73.24

CVS beats class certification bid in generic drug overcharging case

A federal judge has denied a bid by CVS Health Corp customers for class certification in a $1.23 billion lawsuit accusing the pharmacy chain of systematically overcharging people who bought generic drugs using insurance rather than cash.

Mar 22 2017

When CVS stopped selling cigarettes, some customers quit smoking

(Reuters Health) - - The retail pharmacy company CVS Health helped its customers quit smoking by pulling cigarettes off the shelves two years ago, a new study suggests.

Mar 20 2017

BRIEF-CVS Health to launch reduced RX

* CVS Health Corp says will launch reduced RX, a prescription savings program that will offer discounts on certain medications

Mar 16 2017

BRIEF-CVS Health says caremark clients saw prescription drug trend drop to avg. of 3.2 pct in 2016

* CVS Health PBM clients achieved lowest prescription drug trend in four years, despite rising drug prices

Mar 15 2017

CVS removes artificial trans fats from its food brands

CVS Health Corp said its pharmacy chain had removed artificial trans fats, which have been linked to rising rates of heart diseases, from its store-branded food products well ahead of a June 2018 federal deadline.

Feb 22 2017

CVS removes artificial trans fats from its food brands

Feb 22 CVS Health Corp said its pharmacy chain had removed artificial trans fats, which have been linked to rising rates of heart diseases, from its store-branded food products well ahead of a June 2018 federal deadline.

Feb 22 2017

CVS defends PBM industry against drug price hikes

Drugstore chain and pharmacy benefits manager CVS Health Corp defended the industry on Thursday, saying any suggestion that PBMs are causing drug prices to rise was "simply erroneous".

Feb 09 2017

UPDATE 3-CVS defends PBM industry against drug price hikes

* Q4 revenue rises 11.7 pct to $45.97 bln vs. est. $46.50 bln

Feb 09 2017

BRIEF-CVS Health reports Q4 adj. EPS $1.71

* Qtrly same store sales decreased 0.7 pct versus prior year, with pharmacy same store sales up 0.2 pct

Feb 09 2017

CVS Health quarterly revenue rises 11.7 pct

Feb 9 Drugstore chain and pharmacy benefits manager CVS Health Corp reported an 11.7 percent rise in quarterly revenue on Thursday, helped by strength in its PBM business.

Feb 09 2017

More From Around the Web

Earnings vs. Estimates